Equity Research Report: e.l.f. Beauty, Inc. ($ELF)
Current Price: $53.81 | Rating: HOLD | Fair Value: $72 | 12-Mo Target: $72
One-Page Summary
ELF is a beaten-down Gen Z mass-beauty leader (-76% from $221.33 peak in Feb 2024, -31% YoY) sitting almost exactly on critical 200-day support of $52.59. The thesis crack is not the tariff exposure itself but the August 2025 price hike that cost 5 points of unit volume in Q4 FY26 — eroding the very accessibility moat the brand was built on. With Rhode (Hailey Bieber) acquisition delivering $390M FY26 revenue at 80%+ growth but the core ELF franchise softening, the path to fair value requires both tariff clarity by Nov 2026 AND Rhode sustaining $300M+ annualized run rate. Conviction is low.
Top 5 Reasons (mixed signal — 3 bull, 2 bear):
- (Bull) Forward P/E of 16.1x is materially cheaper than Estée Lauder at 29.2x despite triple the revenue growth (+25% FY26 vs. EL +4%).
- (Bull) Adj EV/EBITDA of ~11.4x sits below sector M&A median 14.9x and ELF's own 3-year average ~18x — quantifiable value setup.
- (Bull) Rhode delivered $390M FY26 net sales at 80%+ growth; Sephora Europe launch across 19 countries (Sept 2026) is an under-modeled revenue runway.
- (Bear) Insider selling: 33 sales vs. 0 purchases in past 6 months; CEO Tarang Amin sold $2.64M on Apr 27 — three weeks before disappointing earnings.
- (Bear) Sell-side capitulating — Piper Sandler $50, B. Riley $70 (from $130), UBS $80; consensus broken, no near-term institutional buyer.
1. Company Overview
e.l.f. Beauty, Inc. (NYSE: ELF) is a US-headquartered mass cosmetics manufacturer that combines prestige-quality formulations with $5–$15 mass-market price points. The company sells primarily through Target (18% of revenue), Walmart (13%), Amazon (11%), and Sephora (10%), plus a 24% DTC e-commerce channel. Following the Aug 5, 2025 close of the $800M + $200M earnout acquisition of Rhode (Hailey Bieber's lifestyle beauty brand), ELF now operates a dual portfolio: the core ELF Cosmetics value brand and Rhode at a premium $25–$35 ASP tier. FY26 net sales hit $1,636.5M (+25% YoY), marking the seventh consecutive year of growth. Approximately 55% of production remains China-sourced after diversification efforts (down from ~80% pre-tariff crisis).
2. Price Chart
3. Technical Setup
Trend: Primary downtrend with accelerating weakness; -20% drop in one month following weak guidance despite revenue beat signals continued institutional selling pressure.
Wyckoff Phase: Distribution Phase (E — Final Decline). Stock collapsed 76% from peak; recent earnings-driven selloff after guidance miss indicates exhaustion of buyer support. Currently testing critical 200-day support suggests transition to potential Markdown or capitulation bottom.
Key Levels:
| Level | Price | Significance |
|---|---|---|
| R2 (5yr High) | $221.33 | Resistance; Feb 2024 peak — 311% above current price |
| R1 (200d High) | $150.27 | Intermediate resistance; 179% above current price |
| Current | $53.81 | Testing critical support zone |
| S1 (200d Low) | $52.59 | CRITICAL SUPPORT — Immediate floor; break triggers liquidation cascade |
| S2 (5yr Low) | $21.05 | Fibonacci extension target if S1 breaks; May 2022 floor |
Entry Strategy:
- Bullish: Buy zone $52.59—$54.50, stop loss $51.80 (below S1 by 2.3%)
- Bearish: Short zone $54.50—$55.50, stop loss $56.20 (above R1 rejection)
Ant's verdict: WAIT FOR PULLBACK — Hold for reversal confirmation above $55.00 or breakdown below $52.59 to establish conviction; current positioning at support lacks catalyst for immediate directional commitment.
4. Financial Health
Business Quality — Moat Width: Narrow
- Value-for-money brand equity: ELF offers prestige-quality formulations at mass-market price points ($5–$15 average retail), a positioning difficult to displace — low-income and Gen Z consumers have shown structural loyalty. Q4 FY26 unit volume grew while prestige tier competitors saw flat-to-declining units (until the Aug 2025 price hike disrupted this).
- Social-first, creator-driven marketing flywheel: Marketing/digital spend was $399.8M (24% of FY26 net sales), with TikTok-native campaigns generating earned media at disproportionate scale.
- Mass retail shelf dominance + DTC e-commerce optionality: Top-4 retail customers (Target 18%, Walmart 13%, Amazon 11%, Sephora 10%) provide omnichannel breadth. Channel mix 76% retail / 24% e-commerce.
Financial Snapshot
| Metric | Value | Source | Assessment |
|---|---|---|---|
| Revenue TTM | $1,636.5M | FY26 10-K (Mar 31, 2026) | +25% YoY; Rhode contributed $293.5M of growth |
| Revenue Prior Year (FY25) | $1,312.1M | FY25 10-K | Organic core grew +$29.5M ex-Rhode |
| Free Cash Flow | $190.1M (FCF margin: 11.6%) | StockAnalysis / Cash Flow | Op CF $212.5M less CapEx $22.5M; 65% YoY improvement |
| Cash on Hand | $289.7M | Mar 31, 2026 balance sheet | Up from $149M at Mar 31, 2025 |
| Adj. EBITDA | $335.2M (20.5% margin) | Q4 FY26 earnings release | GAAP EBITDA $153M; gap = $58.5M IEEPA tariffs + SBC + acquisition costs |
| GAAP Profit Margin | -3.0% (net loss -$49.4M) | FY26 10-K | Distorted by tariffs + $93M+ Rhode intangible amortization |
| Book Value per Share | $19.05 | FY26 BS ($1,131M equity / 59.05M shares) | Intangibles = $1,406.6M (59% of total assets) |
| EPS (GAAP Diluted, Q4 FY26) | -$0.82 | 10-K | Trailing P/E distorted; consensus uses adj. EPS |
| Debt / Equity | 0.80x | FY26 balance sheet | Gross debt $841.7M (Term Loan from Rhode); net debt $552M |
| P/E (Trailing GAAP) | ~120x adj. / ~30x normalized | Yahoo / StockAnalysis | Trailing distorted by tariff hits and amortization |
| Forward P/E | 16.1x | Consensus EPS | Implies ~$3.34 adj. EPS for FY27 |
Valuation vs Peers
| Metric | ELF | EL (Estée Lauder) | COTY (Coty) | Sector Avg |
|---|---|---|---|---|
| P/E (Trailing) | ~120x (GAAP-distorted) | N/A (net loss TTM) | N/A (net loss TTM) | ~24x (excl. loss cos.) |
| Forward P/E | 16.1x | 29.2x | 5.98x | ~18–22x |
| P/B | 2.76x | 8.0x | 0.58x | ~3–4x |
| EV/EBITDA (adj.) | ~11.4x | 16.2x | 6.1x | ~14.9x |
| Revenue Growth YoY | +25.0% (FY26) | +4% (FY26 est.) | -1% (Q3 FY26) | +4–6% |
| Profit Margin (GAAP) | -3.0% | -1.7% | -9.2% | +5–8% (excl. loss cos.) |
ELF's forward P/E of 16.1x is materially cheaper than Estée Lauder at 29.2x despite triple the revenue growth. Adj EV/EBITDA of ~11.4x is at or below sector M&A median, suggesting value vs. peers on an operational earnings basis.
5. Ownership & Capital Structure
Top Active Institutional Holders (13F Q1 2026, ETFs/index funds excluded)
| Holder | Shares | Est. Market Value | Type | Notes |
|---|---|---|---|---|
| Baillie Gifford & Co. | 7,188,005 | ~$387M | Active growth (Edinburgh) | Largest single holder ~12.1% of float; reduced 172,019 in Q1 2026 |
| JPMorgan Chase & Co. | 2,236,734 | ~$120M | Active/multi-strategy | Mixed active + prop desk |
| T. Rowe Price Associates | 2,067,396 | ~$111M | Active fundamental growth | Added 711,540 shares (+48%) Q4 2025 |
| ClearBridge Investments | 1,772,528 | ~$95M | Active growth/GARP | Added 264,296 shares (+17.5%) Q4 2025 |
| Mackenzie Financial Corp | 759,118 | ~$41M | Active (Canadian AM) | Largest non-US active holder |
| Wellington Management | 242,103 | ~$13M | Active fundamental | Reduced materially from peak |
| Janus Henderson Group | 183,507 | ~$10M | Active growth | Small but maintained |
Total institutional ownership: 92.4%. Passive mega-holders (Vanguard 4.3%, BlackRock 9.3%, State Street) excluded.
Recent Funding & Capital Actions
- Term Loan B (Aug 2025): $600M drawn to fund cash portion of Rhode acquisition; variable rate. Total gross debt $841.7M at Mar 31, 2026.
- Rhode stock consideration: $200M of ELF common stock issued at close (Aug 5, 2025) — dilutive.
- Earnout liability: Up to $200M contingent on Rhode 3-year revenue targets; not yet accrued.
- IEEPA tariff refund: ~$58.5M expected following Supreme Court ruling invalidating IEEPA tariff authority; planned reinvestment into FY27 volume-driving spend.
- No new equity issuances announced as of May 26, 2026.
6. Competition & Sector
| Competitor | Parent | Tier | Channels | US Revenue Scale | Differentiator vs ELF |
|---|---|---|---|---|---|
| ELF (incl. rhode) | Standalone (NYSE: ELF) | Mass + masstige | Target/Walmart/Amazon/Sephora/DTC | $1,636.5M FY26 | Value + social-first + Gen Z brand equity |
| Estée Lauder | NYSE: EL | Prestige | Dept stores, Sephora, duty-free | ~$14.4B TTM | Luxury, 30+ brand portfolio, global distribution |
| Coty | NYSE: COTY | Mass + prestige | Drug/mass, e-com, selective retail | ~$5B annualized | Broad license portfolio; structurally declining mass brands |
| Tarte Cosmetics | Kendo (LVMH) | Masstige | Sephora exclusive + DTC | ~$500M est. | Clean beauty, Sephora exclusivity |
| Maybelline | L'Oréal (EPA: OR) | Mass | All mass channels globally | ~$2B+ US | Global R&D scale; losing Gen Z relevance |
| DTC challengers (Rare Beauty, Jones Road, etc.) | Various | Masstige | IG/TikTok DTC + Sephora | $100–300M each | Celebrity-led, high social velocity |
Tailwinds:
- Mass beauty grew +4% to $34.6B H1 2025 (Circana) vs. prestige +2% — consumer trade-down benefit.
- ELF holds #1 brand ranking among US Gen Z (Piper Sandler teen surveys).
- International only 21% of FY26 revenue; rhode Sephora Europe launch (Sept 2026, 19 countries) is structural runway.
- China supply chain diversification: >45% of production now ex-China (up from ~20% pre-tariff crisis).
Headwinds:
- ~55% China-sourced production still faces Section 301 tariffs; FY27 guidance assumes 35% blended rate (vs. 55% FY26).
- Rhode integration: $800M + up-to-$200M earnout for $212M LTM revenue base = 4.4x–4.8x revenue — execution-heavy multiple.
- $93M+ annual intangible amortization creates persistent GAAP losses, limiting some institutional mandates.
- Target/Walmart 2025 SKU rationalization; any shelf-space reduction at top-2 retailers (31% combined) would be materially negative.
- L'Oréal has flagged investment behind Maybelline and NYX at mass — potential ELF shelf-space pressure.
7. 12-Month Catalyst Timeline
| Date / Quarter | Catalyst | Type | Est. Impact |
|---|---|---|---|
| Aug 5, 2026 (est.) | Q1 FY27 earnings — first full quarter annualized Rhode; FY27 guidance reiteration vs. cut | Earnings | High — consensus $440–455M revenue (+12–14%); any miss punishes stock |
| Sept 2026 | rhode Sephora Europe launch across 19 countries | Operational | Medium-High — UK Nov 2025 launch was record; incremental Q2 FY27 revenue |
| Oct–Nov 2026 | Holiday shelf reset — Target, Walmart, Sephora planograms | Operational/Retail | Medium — Q3 FY27 seasonally largest quarter; $20–40M adj EBITDA swing |
| Nov 2026 (est.) | Q2 FY27 earnings — first holiday preview + IEEPA refund timing | Earnings | High — $58.5M refund reinvestment pace; brand investment vs. unit recovery test |
| Nov–Dec 2026 | US tariff policy update — Section 301 renegotiation; IEEPA appellate | Macro/Policy | Very High — reduction to 25% adds $30–50M adj EBITDA; re-escalation forces guide cut |
| Feb 2027 (est.) | Q3 FY27 earnings — holiday sell-through + Rhode SKU performance | Earnings | Medium — confirms Sephora velocity outside UK launch halo |
| Mar 2027 | Rhode earnout measurement period begins ($200M contingent) | Operational | Medium — above-target = GAAP EPS headwind; below = no cash but momentum questions |
| May 2027 (est.) | Q4 FY27 / FY27 full year + FY28 guidance | Earnings | High — Rhode integration scorecard; adj EBITDA margin recovery toward 22–24% target is rerating catalyst |
8. Recent News
| Date | Outlet | Headline | Material? |
|---|---|---|---|
| May 21, 2026 | Investing.com / GuruFocus / B. Riley | Piper Sandler cuts PT to $50 (from $60); B. Riley cuts to $70 (from $130); UBS cuts to $80; JPMorgan to $80; BofA to $85 — all post-Q4 earnings | Yes — wave of PT cuts signals institutional consensus breakdown |
| May 20, 2026 | CNBC / Retail Dive / WWD | Q4 FY26 earnings: $449M revenue + adj EPS $0.32 beat, but FY27 guidance $1.84–$1.87B and adj EPS $3.27–$3.32 well below $3.61 Street; CEO Amin reverses price hikes; GAAP net loss $49.4M; Keys Soulcare returned to Alicia Keys | Yes — guidance miss + price reversal admission drove next-day sell-off |
| Apr 27, 2026 | MarketBeat / SEC | Six insiders sell $10M same day — CEO Tarang Amin ($2.64M), CCO Hartnett ($1.33M), SVP Operations Franks ($1.5M) | Yes — cluster selling at elevated levels 3 weeks before earnings; bearish signal |
| Apr 2, 2026 | Investing.com | Evercore ISI initiates ELF at In-Line; no upside thesis | Moderate — no near-term catalyst |
| Feb 4, 2026 | CNBC / IR / Cosmetics Business | Q3 FY26: revenue $489.5M (+38%), adj EPS $1.24 vs $0.72 est; Rhode $128M; Sephora UK blockbuster; FY guide raised | Yes — temporary rally; set up later Q4 disappointment |
| Nov 5, 2025 | CNBC / Yahoo / ainvest | Q2 FY26: stock plunges 29% on weak FY26 guidance + $50M+ tariff cost disclosure; gross margin compression | Yes — single largest negative catalyst of the year; re-rated the stock |
| Aug 5, 2025 | Business of Fashion / Retail Dive | Rhode acquisition closes $800M cash + $200M earnout; Bieber named Chief Creative Officer | Yes — defined FY26 growth thesis; Rhode delivered $390M FY26 sales at 80%+ growth |
| May 28, 2025 | IR / BeautyMatter | ELF announces $1B definitive agreement to acquire Rhode | Yes — initially well-received; framed as Gen Z empire expansion |
9. M&A & Rumor Watch
Rhode integration (closed Aug 5, 2025, $800M + $200M earnout): Operationally successful — Rhode delivered ~$390M FY26 net sales at 80%+ YoY growth; Sephora UK launch (Q3 FY26) was record-breaking. The 3-year earnout structure pressures management to sustain Rhode trajectory even as core ELF demand softens.
Keys Soulcare divestiture (announced May 20, 2026): ELF transferring the Keys Soulcare brand back to founder Alicia Keys. No financial terms disclosed. Signals strategic focus-narrowing — pruning non-core to free resources for Rhode and core ELF.
Insider selling — concentrated and ongoing: Six insiders sold $10,003,086 on April 27, 2026 (CEO Amin $2.64M, 41,520 shares at $63.66). Over past 6 months: 33 sales vs. 0 purchases (Marketbeat). Total: $13.3M sales vs. $0.5M purchases — one of the most lopsided insider patterns among mid-cap consumer names.
No credible M&A rumors beyond Rhode integration. No activist filings as of May 26, 2026.
10. Social Sentiment
Overall mood: Bearish, with a short-term retail contrarian spike post-earnings.
Retail vs Institutional: Retail on Stocktwits flipped to "extremely bullish" immediately after the post-earnings drop — classic dip-buy reflex; message volume up 4,675% in 24 hours. Institutional sentiment is capitulating — multi-firm PT cuts and Evercore neutral initiation signal no institutional buyer conviction.
Trending narratives:
- "Price reversal exposes the tariff trap" — Aug 2025 price hike backfired; Q4 lost 5 points of unit volume. ELF built its brand on value; the moment it raised prices, Gen Z substituted. Retail Dive ran "price hike backfired" framing.
- "Rhode is the only thing working" — $390M at 80%+ growth is the only unambiguous bright spot; bears argue $800M+ was paid for synergies now propping up a deteriorating core.
- "Macro squeeze on the value consumer" — CEO referenced consumers "suffering" from gas prices (citing $15–20M Iran war impact) — suggesting income pressure on ELF's core demographic.
Notable voices:
- Tarang Amin (CEO, CNBC May 20): Admitted price hikes hurt units, pivoting to price reductions — credibility-neutral at best.
- Piper Sandler (PT $50, May 21): Most bearish institutional voice; target = essentially 200-day low; cited demand concerns.
- Olivia Tong, Raymond James (PT $85 from $100): Historically constructive analyst trimmed — notable because RJ is slower to capitulate; sell-side consensus shift is now broad-based.
Sentiment shift (past 30 days): Sharply negative. April 27 insider cluster ($10M) eroded confidence pre-earnings. May 20 Q4 — despite EPS beat — was the inflection: guidance miss, GAAP loss, price reversal admission, Keys Soulcare exit all simultaneous. PT collapses (B. Riley -46% from $130 to $70).
Sentiment score: 1.5 / 5
11. Bull vs Bear Case
| Bull Case | Bear Case | |
|---|---|---|
| Valuation | Forward P/E 16.1x is half EL's 29.2x with 6x the growth | GAAP loss + $93M annual amortization = persistent earnings drag |
| Tariffs | $58.5M IEEPA refund + Section 301 reduction to 25% adds $30–50M adj EBITDA | Re-escalation to 55%+ blended causes -$75–90M adj EBITDA hit; stock to $30–38 |
| Rhode | $390M FY26 sales at 80% growth; Sephora Europe (Sept 2026) under-modeled | $800M paid at the top; thesis breaks if Rhode growth decelerates below $300M annualized |
| Core brand | #1 Gen Z brand ranking; mass beauty +4% vs prestige +2%; price hikes reversed restores accessibility moat | Aug 2025 +$1 price hike cost 5 points of unit volume — accessibility brand promise damaged |
| Insiders | Trough of selling cycle; valuation now compelling for repeat insider buying | 33 sells vs. 0 buys in 6 months including CEO 3 weeks before earnings — management doesn't believe |
| Technicals | Sitting on 5-year structural support; capitulation low setting up | Distribution Phase E final decline; break of $52.59 opens trap door to $35–40 |
| Sell-side | Median PT still $103–118 — recovery path acknowledged | Piper $50, B. Riley $70 (-46%), UBS $80 — entire sell-side rebasing lower |
| Path to $72 FV | Tariff clarity Nov 2026 + Rhode sustains $300M+ run-rate | Either fails → fair value drops to $35–45 |
12. The Verdict
| Metric | Value |
|---|---|
| Rating | HOLD |
| Fair Value | $72 (+34% upside) |
| 12-Month Price Target | $72 |
| Bull-Case Target | $90–100 (tariff cut + Rhode + shelf expansion) |
| Bear-Case Target | $35–40 (tariff re-escalation + Rhode miss + SKU cuts) |
| Conviction | Low-Medium |
| Entry Zone (Bullish) | $52.59–$54.50 |
| Stop Loss | $51.80 (below 200-day low) |
| Key Risk | Tariff re-escalation — Section 301 returning to 55%+ blended would force a guidance cut and push the stock into the low-$30s |
| Conditions to Upgrade | (1) IEEPA refund actually received + reinvestment driving unit volume recovery; (2) Two consecutive quarters of Rhode tracking above $300M annualized; (3) Tariff framework with China formalized below 30% |
| Conditions to Downgrade | (1) Break of $52.59 200-day low on volume; (2) Q1 FY27 guidance cut; (3) Additional insider selling cluster |
ELF is a quantifiably cheap, dominant-brand mid-cap whose core thesis was just punctured by self-inflicted execution — the price hike backfire. Forward valuation supports the $72 fair value, but the path requires two macro/operational items both going right. With sell-side capitulating, insiders selling heavily, and the stock pinned to critical support, this is a wait-and-prove-it setup rather than a buyable capitulation. Initiate only on confirmed reversal above $55.00 with volume; size half-position if tariff resolution materializes by Q1 FY27 earnings (Aug 2026).
Disclaimer: For informational purposes only. Not investment advice.